 - Measurable disease according to RECIST andor, evaluable disease by serum markers in the case of prostate and ovarian cancer according to the Prostate-Specific Antigen Working Group Recommendations PSAWGR and the Gynecologic Cancer Intergroup GCIG specific criteria, respectively. 